BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10675361)

  • 1. Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin.
    Li Y; Hao Y; Owyang C
    J Clin Invest; 2000 Feb; 105(3):351-9. PubMed ID: 10675361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
    Herzig KH; Schön I; Tatemoto K; Ohe Y; Li Y; Fölsch UR; Owyang C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7927-32. PubMed ID: 8755579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion.
    Lu L; Louie D; Owyang C
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G430-5. PubMed ID: 2465698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide.
    Herzig KH; Louie DS; Owyang C
    Am J Physiol; 1994 Jun; 266(6 Pt 1):G1156-61. PubMed ID: 7517637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide.
    Miyasaka K; Guan DF; Liddle RA; Green GM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G175-81. PubMed ID: 2764106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for autoregulation of cholecystokinin secretion during diversion of bile pancreatic juice in rats.
    Li Y; Hao Y; Owyang C
    Gastroenterology; 1995 Jul; 109(1):231-8. PubMed ID: 7797020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats.
    Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
    Pancreas; 2002 Apr; 24(3):269-75. PubMed ID: 11893935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats.
    Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
    Pancreas; 2001 Nov; 23(4):414-20. PubMed ID: 11668212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the action of the novel cholecystokinin-releasing peptide diazepam binding inhibitor by inhibitory hormones and taurocholate.
    Herzig KH; Wilgus C; Schön I; Tatemoto K; Fölsch UR
    Regul Pept; 1998 Jun; 74(2-3):193-8. PubMed ID: 9712181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats.
    Louie DS; May D; Miller P; Owyang C
    Am J Physiol; 1986 Feb; 250(2 Pt 1):G252-9. PubMed ID: 3953805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminal feedback regulation, monitor peptide, CCK-releasing peptide, and CCK receptors.
    Miyasaka K; Funakoshi A
    Pancreas; 1998 Apr; 16(3):277-83. PubMed ID: 9548667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative feedback control of exocrine pancreatic secretion: role of cholecystokinin and cholinergic pathway.
    Owyang C
    J Nutr; 1994 Aug; 124(8 Suppl):1321S-1326S. PubMed ID: 7914921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptone stimulates CCK-releasing peptide secretion by activating intestinal submucosal cholinergic neurons.
    Li Y; Owyang C
    J Clin Invest; 1996 Mar; 97(6):1463-70. PubMed ID: 8617879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats.
    Fölsch UR; Cantor P; Wilms HM; Schafmayer A; Becker HD; Creutzfeldt W
    Gastroenterology; 1987 Feb; 92(2):449-58. PubMed ID: 2431952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of secretin in negative feedback regulation of postprandial pancreatic secretion in dogs.
    Imamura M; Lee KY; Song Y; Moriyasu M; Chang TM; Chey WY
    Gastroenterology; 1993 Aug; 105(2):548-53. PubMed ID: 8335209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a cholecystokinin-releasing peptide: biochemical characterization and physiological implications.
    Owyang C
    Chin J Physiol; 1999 Sep; 42(3):113-20. PubMed ID: 10707884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of intestinal concentration of cholecystokinin by bile and/or pancreatic juice.
    Miyasaka K; Funakoshi A; Matsumoto M; Kitani K
    Dig Dis Sci; 1993 Apr; 38(4):674-9. PubMed ID: 8462366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory capacity of pancreatic protein during luminal feedback regulation in conscious rats.
    Okubo K; Masuda M; Miyasaka K; Funakoshi A
    Jpn J Physiol; 1994; 44(2):205-19. PubMed ID: 7967222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of taurocholate on CCK release and pancreatic secretion produced by two CCK-releasing peptides in conscious rats.
    Miyasaka K; Funakoshi A; Shikado F; Uda K; Kitani K
    Pancreas; 1992; 7(5):536-42. PubMed ID: 1513801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cholecystokinin secretion by intraluminal releasing factors.
    Liddle RA
    Am J Physiol; 1995 Sep; 269(3 Pt 1):G319-27. PubMed ID: 7573441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.